ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CALA Calithera Biosciences Inc

0.20
0.00 (0.00%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.16
Ask Price 0.35
News -
Company Name Stock Ticker Symbol Market Type
Calithera Biosciences Inc CALA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.20 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.20 0.20
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.20 USD

Calithera Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
146.18k 4.87M - 0 -21.29M -4.37 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Calithera Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CALA Message Board. Create One! See More Posts on CALA Message Board See More Message Board Posts

Historical CALA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years2.185.100.1390.86305251,199,520-1.98-90.83%
5 Years6.118.180.1392.23941,094-5.91-96.73%

Calithera Biosciences Description

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Your Recent History

Delayed Upgrade Clock